08-11-2009, 05:22 PM
|
#1
|
|
Webmaster
Join Date: Feb 2005
Location: Home of the "Flying Tomato"
Carlsbad, CA
Posts: 2,036
|
T-DM! Trial Update
A Study of Trastuzumab-MCC-DM1 (T-DM1) in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer and the Safety and Tolerability of Combined T-DM1 and Pertuzumab in Patients With Early Disease Progression
Genentrech has added additional sites to the above trial:
Locations:
United States, Illinois
Decatur Memorial Hosp & CCSCI
2300 North Edward Street
Decatur IL 62526USA
United States, Indiana
Horizon Onc Ctr-Lafayette
1345 Unity Place
Suite 345
Lafayette IN 47905 USA
United States, Maine
Maine Ctr for Cancer Medicine
100 Campus Drive
Unit 108
Scarborough ME 04074 USA
United States, Maryland
Annapolis Medical Specialists
900 Bestgate
Suite 300
Annapolis MD 21401 USA
United States, Missouri
Capitol Comprehensive CA Care
1241 West Stadium Blvd
Jefferson City MO 65109 USA
United States, Ohio
Mid Ohio Onc Hematology Inc
The Mark H. Zangmeister Center
3100 Plaza Properties Blvd.
Columbus OH 43219 USA
Regards
Joe
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.
Illegitimi non carborundum
My Album
|
|
|
Threaded Mode